← Evidence map

ArticleCureus2023

Exploring the High-Grade and Refractory Neurotoxicity of Teclistamab: An Underreported Entity.

Forat Lutfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38130552